Allogeneic Mesothelioma Tumor Lysate-pulsed Autologous Dendritic Cell Vaccine


Dendritic Cell Vaccine. NCI T hesaurus. Code C121640. A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with a mixture of lysates from five allogeneic mesothelioma tumor cell lines, with potential immunostimulatory and antineoplastic activities. Upon leukapheresis, DCs are loaded with allogeneic mesothelioma tumor cell lysates. Upon re-administration of the allogeneic mesothelioma tumor lysate-pulsed autologous DC vaccine, the immune system is exposed to an undefined amount of mesothelioma-associated antigens, which stimulates the induction of a specific cytotoxic T -lymphocyte (CT L) response against mesothelioma tumor cells and leads to tumor cell lysis.
Allogeneic Mesothelioma Tumor Lysate-pulsed Autologous Dendritic Cell Vaccine